LMO4. By Western blot the antibody recognizes a band at ~18 kDa on MCF-7, human breast carcinoma cell line lysate.
Immunogen
Synthetic peptide.
Application
Detect LMO4 using this Anti-LMO4 Antibody validated for use in WB.
Research Category Neuroscience
Research Sub Category Developmental Neuroscience
Neuroregenerative Medicine
Western blot: 1-5 μg/mL on MCF-7, human breast carcinoma cell line lysate.
Optimal working dilutions must be determined by end user.
Target description
18 kDa
Physical form
ImmunoAffinity Purified
Liquid in PBS with 0.1% sodium azide.
Storage and Stability
6 months at 4°C from date of shipment
Legal Information
CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany
Disclaimer
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Not finding the right product?
Try our Product Selector Tool.
Storage Class
10 - Combustible liquids
wgk_germany
WGK 2
flash_point_f
Not applicable
flash_point_c
Not applicable
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.